Unione Europea - tedesco - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva, selektive immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Unione Europea - tedesco - EMA (European Medicines Agency)

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Unione Europea - tedesco - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Unione Europea - tedesco - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostata-neoplasmen - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Belgio - tedesco - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heel belgium - sonnentau (drosera rotundifolia); sonnentau (drosera rotundifolia); sonnentau (drosera rotundifolia); sonnentau (drosera rotundifolia); cuprum aceticum; cuprum aceticum; cuprum aceticum; cuprum aceticum - tropfen zum einnehmen, lösung - sonnentau (drosera rotundifolia) ; sonnentau (drosera rotundifolia) ; sonnentau (drosera rotundifolia) ; sonnentau (drosera rotundifolia) ; cuprum aceticum ; cuprum aceticum ; cuprum aceticum ; cuprum aceticum

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh (3061574) - cuprum aceticum (pot.-angaben); drosera (pot.-angaben) - flüssige verdünnung zur injektion - teil 1 - flüssige verdünnung zur injektion; cuprum aceticum (pot.-angaben) (02035) 25 milligramm; cuprum aceticum (pot.-angaben) (02035) 25 milligramm; cuprum aceticum (pot.-angaben) (02035) 25 milligramm; cuprum aceticum (pot.-angaben) (02035) 25 milligramm; drosera (pot.-angaben) (02130) 25 milligramm; drosera (pot.-angaben) (02130) 25 milligramm; drosera (pot.-angaben) (02130) 25 milligramm; drosera (pot.-angaben) (02130) 25 milligramm - nagetiere, kleine; ziege; katze; schwein; pferd; schaf; kaninchen, nicht zur lebensmittelproduktion; ziervogel; rind; hund

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh (3061574) - cuprum aceticum (pot.-angaben); drosera (pot.-angaben) - mischung - teil 1 - mischung; cuprum aceticum (pot.-angaben) (02035) 0,05 gramm; cuprum aceticum (pot.-angaben) (02035) 0,05 gramm; cuprum aceticum (pot.-angaben) (02035) 0,05 gramm; cuprum aceticum (pot.-angaben) (02035) 0,05 gramm; drosera (pot.-angaben) (02130) 0,05 gramm; drosera (pot.-angaben) (02130) 0,05 gramm; drosera (pot.-angaben) (02130) 0,05 gramm; drosera (pot.-angaben) (02130) 0,05 gramm

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh (3061574) - solanum dulcamara (pot.-angaben); araneus diadematus (pot.-angaben) - mischung - teil 1 - mischung; solanum dulcamara (pot.-angaben) (02354) 0,05 gramm; solanum dulcamara (pot.-angaben) (02354) 0,05 gramm; solanum dulcamara (pot.-angaben) (02354) 0,05 gramm; solanum dulcamara (pot.-angaben) (02354) 0,05 gramm; araneus diadematus (pot.-angaben) (09348) 0,05 gramm; araneus diadematus (pot.-angaben) (09348) 0,05 gramm; araneus diadematus (pot.-angaben) (09348) 0,05 gramm; araneus diadematus (pot.-angaben) (09348) 0,05 gramm

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh (3061574) - cuprum aceticum (pot.-angaben); drosera (pot.-angaben) - flüssige verdünnung zur injektion - teil 1 - flüssige verdünnung zur injektion; cuprum aceticum (pot.-angaben) (02035) 5,5 milligramm; cuprum aceticum (pot.-angaben) (02035) 5,5 milligramm; cuprum aceticum (pot.-angaben) (02035) 5,5 milligramm; cuprum aceticum (pot.-angaben) (02035) 5,5 milligramm; drosera (pot.-angaben) (02130) 5,5 milligramm; drosera (pot.-angaben) (02130) 5,5 milligramm; drosera (pot.-angaben) (02130) 5,5 milligramm; drosera (pot.-angaben) (02130) 5,5 milligramm

Germania - tedesco - myHealthbox

accord healthcare limited - pantoprazol - pulver zur herstellung einer injektionslösung - 40mg - mittel bei säurebedingten erkrankungen, protonenpumpenhemmer - refluxösophagitis; magengeschwür und zwölffingerdarmgeschwür; zollinger-ellison-syndrom und anderen erkrankungen mit hypersekretion von magensäure.